Bright Minds Biosciences (DRUG) Shares Outstanding (Diluted Average) (2020 - 2025)

Bright Minds Biosciences has reported Shares Outstanding (Diluted Average) for 6 years, with the latest figure at $5.6 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 77746911.88% year-over-year to $5.6 million; the trailing twelve-month figure through Dec 2025 stood at $5.6 million (up 77746911.88% YoY), and the FY2024 full-year result was $124.62, down 100.0% from the prior year.
• Shares Outstanding (Diluted Average) for Q4 2025 stood at $5.6 million, up from $5.1 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $9.4 million in Q4 2021, with the low at $7.16 in Q4 2024.
• Historically, Shares Outstanding (Diluted Average) has averaged $3.9 million across 5 years, with a median of $2.8 million in 2023.
• Annual changes were most pronounced in 2024 — Shares Outstanding (Diluted Average) plunged 100.0% — and 2025, when it surged 77746911.88%.
• Bright Minds Biosciences' Shares Outstanding (Diluted Average) stood at $9.4 million in 2021, then slumped by 99.99% to $478.86 in 2022, then surged by 589342.1% to $2.8 million in 2023, then sank by 100.0% to $7.16 in 2024, then surged by 77746911.88% to $5.6 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $5.6 million (Q4 2025), $5.1 million (Q2 2025), and $4.9 million (Q1 2025), per Business Quant data.